好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cerebral Venous Thrombosis in Adults Aged Over 50 Years: A Retrospective Study From a Latin American Center
Cerebrovascular Disease and Interventional Neurology
P1 - Poster Session 1 (8:00 AM-9:00 AM)
4-003
To describe demographic, clinical, and radiographic features of cerebral venous thrombosis (CVT) in patients aged ≥50 years at a single center and to compare findings with global literature
Cerebral venous thrombosis (CVT) is an uncommon cause of stroke resulting from thrombosis of cerebral veins or dural sinuses. Although it predominantly affects young adults and women, older adults can also be affected, often with different risk profiles and outcomes. Understanding the influence of age-related and autoimmune risk factors is essential for prevention and early recognition. Despite its clinical importance, data from Latin America remain limited, hindering the global understanding of this condition in older populations.
We conducted a retrospective review of all patients diagnosed with CVT aged ≥50 years in our hospital’s database. Demographic, clinical, and radiological variables were extracted, including sex, autoimmune comorbidities, and sinus involvement. Descriptive statistics were calculated. A focused literature review was performed to contextualize the findings within the international experience.

Fifty patients were included (mean age 62.2 years); 54% were male and 46% female. Autoimmune disorders—mainly antiphospholipid syndrome, systemic lupus erythematosus, and thyroid dysfunction—were found in 16% of cases. The most frequently affected sinuses were the rectus (4%) and cavernous (4%), with occasional superior petrosal involvement (2%). Compared with global reports, where CVT accounts for 0.5–1% of strokes and typically affects younger women, our findings indicate a higher age at presentation, balanced sex distribution, and similar autoimmune association. This series provides region-specific data that contribute to filling existing epidemiologic gaps in Latin America.


CVT in adults aged ≥50 years presents distinct demographic and clinical characteristics compared with younger cohorts. These findings emphasize the need for increased recognition of CVT in older patients and for expanded multicenter studies across Latin America to better define risk factors and guide prevention.
Authors/Disclosures
Andres Ricaurte, MD (Weill Medical College of Cornell University)
PRESENTER
Dr. Ricaurte has nothing to disclose.
Andres Felipe Cardenas Cruz, Jr., MD (Javeriana) Dr. Cardenas Cruz has nothing to disclose.
Valentina Velasco Miss Velasco has nothing to disclose.
Silvia A. Andrade Rondón, Sr., PT Dr. Andrade Rondón has nothing to disclose.
Carlos Alvarado-De la Hoz, MD Dr. Alvarado-De la Hoz has nothing to disclose.
Isabel Torres-Camacho Dr. Torres-Camacho has nothing to disclose.
Elkin Garcia-Cifuentes, MD Dr. Garcia-Cifuentes has nothing to disclose.
María P. Ardila, MD No disclosure on file
Betty J. Arevalo, MD Miss Arevalo has nothing to disclose.
Carlos Beltrán Mr. Beltrán has nothing to disclose.
Laura Monsalve Dr. Monsalve has nothing to disclose.
Luis Roa Luis Roa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer. Luis Roa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PFIZER. Luis Roa has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BOSTON SCIENTIFIC.
Juliana Coral, MD Dr. Coral has nothing to disclose.